News | Radiation Therapy | August 10, 2016

Accuray CE Marks New Radixact Radiotherapy System

Next-generation image-guided radiation therapy platform and integrated software now available for use by clinicians in the European Union

Accuray, Radixact Treatment Delivery Platform, image-guided radiation therapy, AAPM, CE Mark

August 10, 2016 — Accuray Inc. announced that it has CE marked its Radixact Treatment Delivery System, Accuray Precision Treatment Planning System and iDMS Data Management System. The next-generation hardware and software solutions, together, make up the new Radixact radiation therapy platform, which represents a major step forward in the evolution of Accuray's existing TomoTherapy System in treatment speed and ease of use.

The platform will now be available in certain markets in the European Union (EU), in addition to the U.S. market where it received U.S. Food and Drug Administration (FDA) 510(k) clearance in June 2016.

The Radixact System is a "smart" system that will enable faster, more efficient delivery of extremely precise treatment to a wider range of cancer patients across the European market. It features a more powerful linear accelerator, megavoltage computed tomography (MVCT) imaging and helical treatment delivery, so clinicians can apply highly conformal and homogeneous dose distributions to any target volume, while precisely sparing normal healthy tissue during each treatment fraction.  

The Radixact platform is comprised of three entirely new technologies:

  • Radixact Treatment Delivery System: Taking the capabilities of the TomoTherapy Systems to a new level;
  • Accuray Precision Treatment Planning System: Smart, automated workflows and mid-course decision-making tools that enable clinicians to adapt delivery according to changes in tumor size, shape and location; and
  • iDMS Data Management System: Seamless management of patient data across multiple Radixact Systems and clinics, from a single point of control.

For more information: www.accuray.com

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...